Segal Lloyd Mitchell

CIK 00014771233 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001477123

Recent Transactions

50 trades

Conversion
Aktis Oncology, Inc.$AKTS
Series A Redeemable Convertible Preferred Stock
2026-01-12−50,000→ 0 total
Conversion
Aktis Oncology, Inc.$AKTS
Common Stock
2026-01-12+19,631→ 19,631 total
Conversion
Aktis Oncology, Inc.$AKTS
Series B Redeemable Convertible Preferred Stock
2026-01-12−24,687→ 0 total
Sale
Repare Therapeutics Inc.$RPTX
Common Shares
2025-03-12$1.14/sh−21,179→ 124,394 total
Award
Repare Therapeutics Inc.$RPTX
Common Shares
2025-03-04+40,000→ 145,573 total
Award
Repare Therapeutics Inc.$RPTX
Employee Stock Option (right to buy)
2025-03-04+237,000→ 237,000 total
Sale
Repare Therapeutics Inc.$RPTX
Common Shares
2024-04-01$4.63/sh−2,491→ 107,558 total
Sale
Repare Therapeutics Inc.$RPTX
Common Shares
2024-03-28$4.62/sh−2,650→ 110,049 total
Sale
Repare Therapeutics Inc.$RPTX
Common Shares
2024-03-27$4.63/sh−2,650→ 83,866 total
Sale
Repare Therapeutics Inc.$RPTX
Common Shares
2024-03-26$4.64/sh−2,650→ 86,516 total
Sale
Repare Therapeutics Inc.$RPTX
Common Shares
2024-03-25$4.79/sh−2,650→ 89,166 total
Award
Repare Therapeutics Inc.$RPTX
Common Shares
2024-03-01+40,000→ 124,677 total
Award
Repare Therapeutics Inc.$RPTX
Employee Stock Option (right to buy)
2024-03-01+237,000→ 237,000 total
Award
Repare Therapeutics Inc.$RPTX
Common Shares
2023-01-30+78,550→ 84,677 total
Award
Repare Therapeutics Inc.$RPTX
Employee Stock Option (right to buy)
2023-01-30+344,200→ 344,200 total
Exercise/Conversion
Repare Therapeutics Inc.$RPTX
Employee Stock Option (right to buy)
2022-01-21+300,000→ 300,000 total
Exercise/Conversion
Repare Therapeutics Inc.$RPTX
Employee Stock Option (right to buy)
2022-01-18+300,000→ 300,000 total
Sale
Repare Therapeutics Inc.$RPTX
Common Stock
2021-06-28$35.61/sh−1,542→ 94,466 total
Sale
Repare Therapeutics Inc.$RPTX
Common Stock
2021-06-09$35.00/sh−1,576→ 96,008 total
Sale
Repare Therapeutics Inc.$RPTX
Common Stock
2021-06-04$31.36/sh−12,172→ 97,584 total
Sale
Repare Therapeutics Inc.$RPTX
Common Stock
2021-06-04$31.25/sh−5,000→ 5,000 total
Sale
Repare Therapeutics Inc.$RPTX
Common Stock
2021-06-04$30.64/sh−17,180→ 109,756 total
Exercise/Conversion
Repare Therapeutics Inc.$RPTX
Common Stock
2021-06-04$1.64/sh+5,000→ 10,000 total
Exercise/Conversion
Repare Therapeutics Inc.$RPTX
Employee Stock Option (right to buy)
2021-06-04−5,000→ 283,683 total
Sale
Repare Therapeutics Inc.$RPTX
Common Stock
2021-06-03$31.74/sh−6,648→ 126,936 total
Sale
Repare Therapeutics Inc.$RPTX
Common Stock
2021-05-20$35.03/sh−3,770→ 133,584 total
Sale
Repare Therapeutics Inc.$RPTX
Common Stock
2021-05-19$35.06/sh−3,800→ 137,354 total
Sale
Repare Therapeutics Inc.$RPTX
Common Stock
2021-05-18$35.00/sh−1,800→ 141,154 total
Sale
Repare Therapeutics Inc.$RPTX
Common Stock
2021-04-15$35.01/sh−5,512→ 142,954 total
Award
Repare Therapeutics Inc.$RPTX
Employee Stock Option (right to buy)
2021-02-08+125,000→ 125,000 total
Purchase
Repare Therapeutics Inc.$RPTX
Common Stock
2020-06-23$20.00/sh+5,000→ 5,000 total
Award
Repare Therapeutics Inc.$RPTX
Employee Stock Option (right to buy)
2020-06-18+354,668→ 354,668 total
Purchase
Bausch Health Companies Inc.$BHC
Common Stock, no par value
2013-06-14$85.45/sh+140→ 21,174 total
Purchase
Bausch Health Companies Inc.$BHC
Common Stock, no par value
2013-06-12$83.50/sh+2,500→ 21,034 total
Purchase
Bausch Health Companies Inc.$BHC
Common Stock, no par value
2013-06-11$86.45/sh+200→ 630 total
Purchase
Bausch Health Companies Inc.$BHC
Common Stock, no par value
2013-06-11$86.44/sh+100→ 340 total
Purchase
Bausch Health Companies Inc.$BHC
Common Stock, no par value
2013-06-11$86.48/sh+90→ 430 total
Purchase
Bausch Health Companies Inc.$BHC
Common Stock, no par value
2013-06-11$86.73/sh+300→ 18,534 total
Disposition to Issuer
Bausch Health Companies Inc.$BHC
Deferred Share Units
2013-05-30$90.81/sh−36,270→ 0 total
Disposition to Issuer
Bausch Health Companies Inc.$BHC
Common Stock, no par value
2013-05-30$90.81/sh−4,397→ 18,474 total
Award
Bausch Health Companies Inc.$BHC
Common Shares, no par value
2013-05-24+5,022→ 22,871 total
Purchase
Bausch Health Companies Inc.$BHC
Common Stock, no par value
2012-11-09$54.28/sh+240→ 17,849 total
Purchase
Bausch Health Companies Inc.$BHC
Common Stock, no par value
2012-11-09$54.28/sh+240→ 17,849 total
Purchase
Bausch Health Companies Inc.$BHC
Common Stock, no par value
2012-11-06$54.44/sh+745→ 17,609 total
Award
Bausch Health Companies Inc.$BHC
Common Shares, no par value
2012-06-30+498→ 16,864 total
Award
Bausch Health Companies Inc.$BHC
Common Shares, no par value
2012-06-04+8,062→ 16,366 total
Award
Bausch Health Companies Inc.$BHC
Coomon Shares, no par value
2012-03-31+407→ 8,304 total
Award
Bausch Health Companies Inc.$BHC
Common Stock, no par value
2011-05-19+4,397→ 7,897 total
Award
Bausch Health Companies Inc.$BHC
Deferred Share Units
2011-03-05+1,613→ 36,270 total
Award
Bausch Health Companies Inc.$BHC
Deferred Share Units
2010-12-22+1,163→ 34,657 total

Companies

Recent Filings

Address

C/O AKTIS ONCOLOGY, INC. 17 DRYDOCK AVENUE, SUITE 17-401

BOSTON, MA, 02210

View on SEC.gov